In this multicenter study, baseline QOL was assessed in over 200 patients with stage II or III esophageal cancer who underwent induction therapy and surgery or definitive chemoradiotherapy. Baseline QOL was related to survival independent of age, stage, histologic type, and treatment. It is suggested that assessment of baseline QOL is a prognostic tool that can be used in shared decision making.
You are here:
Baseline measure of health-related quality of life (Functional Assessment of Cancer Therapy-Esophagus) is associated with overall survival in patients with esophageal cancer
Submitted by: Mark Ferguson
Source: Journal of Thoracic and Cardiovascular Surgery
Keywords:
Author(s): Biniam Kidane, Joanne Sulman, Wei Xu, Qin Quinn Kong, Rebecca Wong, Jennifer J. Knox, Gail E. Darling
